Bosh sahifa068270 ā¢ KRX
add
Celltrion Inc
Yopilish kursi
188Ā 900,00Ā ā©
Kunlik diapazon
187Ā 700,00Ā ā© - 191Ā 000,00Ā ā©
Yillik diapazon
138Ā 500,00Ā ā© - 241Ā 000,00Ā ā©
Bozor kapitalizatsiyasi
40,89Ā trln KRW
OŹ»rtacha hajm
555,36Ā ming
Narx/foyda
91,74
Dividend daromadliligi
0,27%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 874,74Ā mlrd | 66,94% |
Joriy xarajat | 295,34Ā mlrd | 216,97% |
Sof foyda | 78,01Ā mlrd | -47,11% |
Sof foyda marjasi | 8,92 | -68,31% |
Har bir ulushga tushum | 377,00 | -63,54% |
EBITDA | 204,70Ā mlrd | -14,53% |
Amaldagi soliq stavkasi | 24,71% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,03Ā trln | 53,19% |
Jami aktivlari | 20,13Ā trln | 220,09% |
Jami passivlari | 3,13Ā trln | 65,33% |
Umumiy kapital | 16,99Ā trln | ā |
Tarqatilgan aksiyalar | 206,33Ā mln | ā |
Narxi/balansdagi bahosi | 2,31 | ā |
Aktivlardan daromad | 0,90% | ā |
Kapitaldan daromad | 0,94% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 78,01Ā mlrd | -47,11% |
Operatsiyalardan naqd pul | 293,61Ā mlrd | 3,31% |
Sarmoyadan naqd pul | 103,88Ā mlrd | 212,18% |
Moliyadan naqd pul | -246,57Ā mlrd | -287,43% |
Naqd pulning sof oŹ»zgarishi | 157,08Ā mlrd | 22,54% |
BoŹ»sh pul | 102,18Ā mlrd | -12,49% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
2Ā 391
